US pharmacy compounding case could head to Supreme Court
This article was originally published in Scrip
Executive Summary
A federal appeals court ruling upholding the USFDA's ability to regulate compounded medicines as new drugs has created different enforcement standards for compounding pharmacies throughout the country and could spur an appeal to the US Supreme Court to resolve the conflict.